Skip to main content
Top
Published in: BMC Gastroenterology 1/2017

Open Access 01-12-2017 | Research article

Comparison of oesophageal function tests between Chinese non-erosive reflux disease and reflux hypersensitivity patients

Authors: Feng Gao, Yan Gao, Xue Chen, Jie Qian, Jie Zhang

Published in: BMC Gastroenterology | Issue 1/2017

Login to get access

Abstract

Background

By means of 24 h multi-channel intraluminal impedance and pH recording (MII/pH), patients with heartburn and normal upper gastrointestinal endoscopy findings can be classified into those with non-erosive reflux disease (NERD) and those with reflux hypersensitivity (RH). Therefore, in this study, we investigated the difference in oesophageal function tests in Chinese patients with NERD and RH.

Methods

NERD patients were selected from the digestive department, Beijing Anzhen Hospital and Beijing Chao-Yang Hospital, Capital Medical University, after upper gastrointestinal endoscope, high-resolution manometry and impedance (HRiM), and MII/pH examinations between 2014 and 2016.

Results

In total, 111 NERD patients with abnormal acid exposure, and 92 RH patients were enrolled. Values for NERD and RH were as follows: lower oesophageal sphincter pressure, 15.3 ± 8.9 and 19.3 ± 23.3 mmHg (P = 0.122); integrated relaxation pressure, 7.5 ± 4.8 and 7.9 ± 5.2 mmHg (P = 0.485); distal contractile integral, 751.9 ± 856.2 and 661.9 ± 961.7 mmHg∙s∙cm (P = 0.482); ineffective oesophageal motility rate, 49.5% and 41.3% (P = 0.241); fragmented peristalsis rate, 5.4% and 9.8% (P = 0.235); hiatal hernia rate, 9.0% and 8.6% (P = 0.938); total bolus transit time, 6.3 ± 1.3 and 6.5 ± 1.3 s (P = 0.119); complete bolus transit rate, 76.1 ± 33.0% and 73.1 ± 32.0% (P = 0.224); total acid exposure time, 6.1 ± 3.7% and 0.8 ± 0.8% (P < 0.001); total bolus exposure time, 2.5 ± 2.1% and 1.5 ± 1.1% (P < 0.001); proximal acid reflux events, 13.2 ± 10.5 and 9.7 ± 8.9 (P = 0.011); distal acid reflux events, 25.3 ± 15.8 and 13.4 ± 11.2 (P < 0.001); post-reflux swallow-induced peristaltic wave index, 25.1 ± 9.5% and 32.6 ± 15.2% (P < 0.001); and mean nocturnal baseline impedance, 1,450.2 ± 750.8 and 2,503.6 ± 964.1 ohms (P < 0.001), respectively.

Conclusions

NERD and RH patients showed similar values on HRiM. NERD patients had greater acid exposure time, bolus exposure time, proximal and distal acid reflux events, and increased impairment of chemical clearance and mucosal integrity than RH patients. NERD and RH should be classified correctly by MII/pH to provide adequate relief from related symptoms.
Literature
1.
go back to reference Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20.CrossRefPubMed Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20.CrossRefPubMed
2.
go back to reference Winter JW, Heading RC. The nonerosive reflux disease-gastroesophageal reflux disease controversy. Curr Opin Gastroenterol. 2008;24(4):509–15.CrossRefPubMed Winter JW, Heading RC. The nonerosive reflux disease-gastroesophageal reflux disease controversy. Curr Opin Gastroenterol. 2008;24(4):509–15.CrossRefPubMed
3.
go back to reference Hachem C, Shaheen NJ. Diagnosis and Management of Functional Heartburn. Am J Gastroenterol. 2016;111(1):53–61.CrossRefPubMed Hachem C, Shaheen NJ. Diagnosis and Management of Functional Heartburn. Am J Gastroenterol. 2016;111(1):53–61.CrossRefPubMed
4.
go back to reference Surdea Blaga T, Dumitrascu D, Galmiche JP. Bruley des Varannes S. Functional heartburn: clinical characteristics and outcome. Eur J Gastroenterol Hepatol. 2013;25(3):282–90.CrossRefPubMed Surdea Blaga T, Dumitrascu D, Galmiche JP. Bruley des Varannes S. Functional heartburn: clinical characteristics and outcome. Eur J Gastroenterol Hepatol. 2013;25(3):282–90.CrossRefPubMed
5.
go back to reference Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional esophageal Disorders. Gastroenterology. 2016;150(6):1368–79.CrossRef Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional esophageal Disorders. Gastroenterology. 2016;150(6):1368–79.CrossRef
6.
go back to reference Tamura Y, Funaki Y, Izawa S, Iida A, Yamaguchi Y, Adachi K, et al. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients. World J Gastroenterol. 2015;21(16):5009–16.CrossRefPubMedPubMedCentral Tamura Y, Funaki Y, Izawa S, Iida A, Yamaguchi Y, Adachi K, et al. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients. World J Gastroenterol. 2015;21(16):5009–16.CrossRefPubMedPubMedCentral
7.
go back to reference Bredenoord AJ, Kahrilas PJ, Pandolfino JE, Schwizer W, Smout AJPM. The International High Resolution Manometry Working Group: Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl1):57–65.CrossRefPubMedPubMedCentral Bredenoord AJ, Kahrilas PJ, Pandolfino JE, Schwizer W, Smout AJPM. The International High Resolution Manometry Working Group: Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl1):57–65.CrossRefPubMedPubMedCentral
8.
go back to reference Kahrilas PJ, Ghosh SK, Pandolfino JE. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol. 2008;42(5):627–35.CrossRefPubMedPubMedCentral Kahrilas PJ, Ghosh SK, Pandolfino JE. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol. 2008;42(5):627–35.CrossRefPubMedPubMedCentral
9.
go back to reference Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.CrossRefPubMed Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.CrossRefPubMed
10.
go back to reference Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, et al. Twenty-Four hour ambulatory simultaneous impedance and pH monitoring : a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99(6):1037–43.CrossRefPubMed Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, et al. Twenty-Four hour ambulatory simultaneous impedance and pH monitoring : a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99(6):1037–43.CrossRefPubMed
11.
go back to reference Kushnir VM, Sathyamurthy A, Drapekin J, Gaddam S, Sayuk GS, Gyawali CP. Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring. Aliment Pharmacol Ther. 2012;35(9):1080–7.PubMedPubMedCentral Kushnir VM, Sathyamurthy A, Drapekin J, Gaddam S, Sayuk GS, Gyawali CP. Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring. Aliment Pharmacol Ther. 2012;35(9):1080–7.PubMedPubMedCentral
12.
go back to reference Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015;13(5):884–91.CrossRefPubMed Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015;13(5):884–91.CrossRefPubMed
13.
go back to reference Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease: a 24 h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25(5):399–406.CrossRefPubMed Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease: a 24 h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25(5):399–406.CrossRefPubMed
14.
go back to reference Martinucci I, De Bortoli N, Savarino E, Piaggi P, Bellini M, Antonelli A, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014;26(4):546–55.CrossRefPubMed Martinucci I, De Bortoli N, Savarino E, Piaggi P, Bellini M, Antonelli A, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014;26(4):546–55.CrossRefPubMed
15.
go back to reference Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, et al. Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion. 2009;80(2):74–88.CrossRefPubMedPubMedCentral Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, et al. Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion. 2009;80(2):74–88.CrossRefPubMedPubMedCentral
16.
go back to reference Dean BB, Gano Jr AD, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2(8):656–64.CrossRefPubMed Dean BB, Gano Jr AD, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2(8):656–64.CrossRefPubMed
17.
go back to reference Wu JC, Cheung CM, Wong VW, Sung JJ. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol. 2007;5(6):690–5.CrossRefPubMed Wu JC, Cheung CM, Wong VW, Sung JJ. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol. 2007;5(6):690–5.CrossRefPubMed
18.
go back to reference Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastrooesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998;10(2):119–24.CrossRefPubMed Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastrooesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998;10(2):119–24.CrossRefPubMed
19.
go back to reference Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol. 2010;105(5):1053–61.CrossRefPubMed Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol. 2010;105(5):1053–61.CrossRefPubMed
20.
go back to reference Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004;16(5):495–501.CrossRefPubMed Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004;16(5):495–501.CrossRefPubMed
21.
22.
go back to reference Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10(6):371–80.CrossRefPubMed Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10(6):371–80.CrossRefPubMed
23.
go back to reference Emerenziani S, Sifrim D, Habib FI, Ribolsi M, Guarino MP, Rizzi M, et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut. 2008;57(4):443–7.CrossRefPubMed Emerenziani S, Sifrim D, Habib FI, Ribolsi M, Guarino MP, Rizzi M, et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut. 2008;57(4):443–7.CrossRefPubMed
24.
go back to reference Emerenziani S, Ribolsi M, Sifrim D, Blondeau K, Cicala M. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Neurogastroenterol Motil. 2009;21(3):253–8.CrossRefPubMed Emerenziani S, Ribolsi M, Sifrim D, Blondeau K, Cicala M. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Neurogastroenterol Motil. 2009;21(3):253–8.CrossRefPubMed
25.
go back to reference Diener U, Patti MG, Molena D, Fisichella PM, Way LW. Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg. 2001;5(3):260–5.CrossRefPubMed Diener U, Patti MG, Molena D, Fisichella PM, Way LW. Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg. 2001;5(3):260–5.CrossRefPubMed
26.
go back to reference Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, et al. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(4):476–86.CrossRefPubMed Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, et al. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(4):476–86.CrossRefPubMed
27.
go back to reference de Miranda Gomes Jr PR, da Rosa AR P, Sakae T, Simic AP, Ricachenevsky Gurski R. Correlation between pathological distal esophageal acid exposure and ineffective esophageal motility. Acta Chir Iugosl. 2010;57(2):37–43.CrossRefPubMed de Miranda Gomes Jr PR, da Rosa AR P, Sakae T, Simic AP, Ricachenevsky Gurski R. Correlation between pathological distal esophageal acid exposure and ineffective esophageal motility. Acta Chir Iugosl. 2010;57(2):37–43.CrossRefPubMed
28.
go back to reference Pandolfino JE, Roman S. High resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography. Thorac Surg Clin. 2011;21(4):465–75.CrossRefPubMedPubMedCentral Pandolfino JE, Roman S. High resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography. Thorac Surg Clin. 2011;21(4):465–75.CrossRefPubMedPubMedCentral
29.
go back to reference William JB, Peter JK, Monika AK, Sudip KG, Albert M, John EP. Esophageal pressure topography criteria indicative of incomplete bolus clearance: a study using high-resolution impedance manometry. Am J Gastroenterol. 2009;104(11):2721–8.CrossRef William JB, Peter JK, Monika AK, Sudip KG, Albert M, John EP. Esophageal pressure topography criteria indicative of incomplete bolus clearance: a study using high-resolution impedance manometry. Am J Gastroenterol. 2009;104(11):2721–8.CrossRef
30.
go back to reference Ribolsi M, Balestrieri P, Emerenziani S, Guarino MP. Cicala Michele. Weak peristalsis with large break is associated with high acid exposure and delayed reflux clearance in the supine position in GERD patients. Am J Gastroenterol. 2014;109(1):46–51.CrossRefPubMed Ribolsi M, Balestrieri P, Emerenziani S, Guarino MP. Cicala Michele. Weak peristalsis with large break is associated with high acid exposure and delayed reflux clearance in the supine position in GERD patients. Am J Gastroenterol. 2014;109(1):46–51.CrossRefPubMed
31.
go back to reference Savarino E, Zentilin P, Tutuian R, Pohl D, Gemignani L, Malesci A, et al. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012;47(2):159–68.CrossRefPubMed Savarino E, Zentilin P, Tutuian R, Pohl D, Gemignani L, Malesci A, et al. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012;47(2):159–68.CrossRefPubMed
32.
go back to reference Shafik A, El-Sibai O, Shafik AA. Mostafa Rl. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action. J Gastroenterol Hepatol. 2005;20(12):1935–9.CrossRefPubMed Shafik A, El-Sibai O, Shafik AA. Mostafa Rl. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action. J Gastroenterol Hepatol. 2005;20(12):1935–9.CrossRefPubMed
33.
go back to reference Frazzoni M, Savarino E, de Bortoli N, Martinucci I, Furnari M, Frazzoni L, et al. Analyses of the Post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14(1):40–6.CrossRefPubMed Frazzoni M, Savarino E, de Bortoli N, Martinucci I, Furnari M, Frazzoni L, et al. Analyses of the Post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14(1):40–6.CrossRefPubMed
34.
go back to reference Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Furnari M, Martinucci I, at al. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnalbaseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. Neurogastroenterol Motil. 2017; 29(3). doi: 10.1111/nmo.12947. Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Furnari M, Martinucci I, at al. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnalbaseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. Neurogastroenterol Motil. 2017; 29(3). doi: 10.​1111/​nmo.​12947.
Metadata
Title
Comparison of oesophageal function tests between Chinese non-erosive reflux disease and reflux hypersensitivity patients
Authors
Feng Gao
Yan Gao
Xue Chen
Jie Qian
Jie Zhang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2017
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-017-0624-7

Other articles of this Issue 1/2017

BMC Gastroenterology 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.